Medicine: Treatment enhances anti-leukemia effect of bone marrow transplant, reduces recurrence, study finds
Researchers at the University of Michigan Health Rogel Cancer Center have identified a drug that, when given along with a bone marrow transplant, drops the risk of leukemia recurring by 20% among the high-risk patients. Ann Arbor, October 25, 2021.- The study, published in Blood Advances, looked at patients withContinuar Leyendo
















